We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Rectangle Image
Webinar

A Successful Journey to Cell Therapy Manufacturing: From Research and Development to Lot-Release

Rectangle Image
Webinar

A Successful Journey to Cell Therapy Manufacturing: From Research and Development to Lot-Release

Kasey Kime
Kasey Kime
Regulatory Affairs
Sean Chang
Sean Chang
Cell and Gene Therapy

Cell therapy is a transformative cancer treatment that utilizes genetically modified cells from a healthy donor or patient's own immune system to attack cancer cells, but manufacturing these cells represents a major challenge for the industry. Although every therapy and process are different, there are a few key decisions that are critical to the success of any advanced therapy medicinal product (ATMP) and for the success of the company that plans to bring them to the clinic.

In this webinar, we will discuss three main areas to consider when you're preparing to commercialize a cell therapy including starting/raw material, the controlled manufacturing process as well as testing safety and quality.

Watch now to learn about:

  • Regulatory requirements for GMP ancillary materials for cell and gene therapy
  • Closed-system manufacturing and how it can improve overall productivity and product safety
  • Characterization and lot release testing, proper validation for regulatory CMC filing
Advertisement